Correlation Between ACELYRIN, INC and Stoke Therapeutics
Can any of the company-specific risk be diversified away by investing in both ACELYRIN, INC and Stoke Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ACELYRIN, INC and Stoke Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ACELYRIN, INC Common and Stoke Therapeutics, you can compare the effects of market volatilities on ACELYRIN, INC and Stoke Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ACELYRIN, INC with a short position of Stoke Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of ACELYRIN, INC and Stoke Therapeutics.
Diversification Opportunities for ACELYRIN, INC and Stoke Therapeutics
-0.13 | Correlation Coefficient |
Good diversification
The 3 months correlation between ACELYRIN, and Stoke is -0.13. Overlapping area represents the amount of risk that can be diversified away by holding ACELYRIN, INC Common and Stoke Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Stoke Therapeutics and ACELYRIN, INC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ACELYRIN, INC Common are associated (or correlated) with Stoke Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Stoke Therapeutics has no effect on the direction of ACELYRIN, INC i.e., ACELYRIN, INC and Stoke Therapeutics go up and down completely randomly.
Pair Corralation between ACELYRIN, INC and Stoke Therapeutics
Given the investment horizon of 90 days ACELYRIN, INC Common is expected to generate 1.42 times more return on investment than Stoke Therapeutics. However, ACELYRIN, INC is 1.42 times more volatile than Stoke Therapeutics. It trades about 0.02 of its potential returns per unit of risk. Stoke Therapeutics is currently generating about -0.07 per unit of risk. If you would invest 457.00 in ACELYRIN, INC Common on September 2, 2024 and sell it today you would lose (2.00) from holding ACELYRIN, INC Common or give up 0.44% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
ACELYRIN, INC Common vs. Stoke Therapeutics
Performance |
| Timeline |
| ACELYRIN, INC Common |
| Stoke Therapeutics |
ACELYRIN, INC and Stoke Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with ACELYRIN, INC and Stoke Therapeutics
The main advantage of trading using opposite ACELYRIN, INC and Stoke Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ACELYRIN, INC position performs unexpectedly, Stoke Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Stoke Therapeutics will offset losses from the drop in Stoke Therapeutics' long position.| ACELYRIN, INC vs. Tff Pharmaceuticals | ACELYRIN, INC vs. Eliem Therapeutics | ACELYRIN, INC vs. Inhibrx | ACELYRIN, INC vs. Enliven Therapeutics |
| Stoke Therapeutics vs. Tff Pharmaceuticals | Stoke Therapeutics vs. Eliem Therapeutics | Stoke Therapeutics vs. Inhibrx | Stoke Therapeutics vs. Enliven Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Complementary Tools
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |